Rubicon Research Limited (RUBICON) Share Analysis
NSE · Healthcare · Healthcare
Rubicon Research Limited (NSE: RUBICON) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹1,751.00, market capitalisation ₹28,986 Cr, P/E 101, ROE 27%.
Get the AI verdict on RUBICON: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
RUBICON price and valuation
- Share price
- ₹1,751.00
- Market cap
- ₹28,986 Cr
- P/E ratio
- 101
- P/B ratio
- 22.42
- EPS
- ₹17.69
- Book value per share
- ₹78.10
- Dividend yield
- 0.09%
RUBICON profitability and growth
- ROE
- 27%
- ROCE
- 28.4%
- Debt to equity
- 0.24
- Revenue growth (3 yr)
- 65%
- Revenue growth (5 yr)
- 41%
- Profit growth (3 yr)
- 155%
- Profit growth (5 yr)
- 52%
RUBICON 52-week range
- 52-week high
- ₹1,899.00
- 52-week low
- ₹570.75
- Face value
- ₹1.00
RUBICON shareholding pattern
- Promoters
- 59.76%
- FIIs
- 7.52%
- DIIs
- 9.43%
- Public
- 23.29%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.